Board of Suven Pharmaceuticals approves investment in a renewable entity
At meeting held on 30 May 2024
The Board of Suven Pharmaceuticals at its meeting held on 30 May 2024 has approved the proposed equity investment of 26% in the SPV (under incorporation) to be engaged in solar power generation for the purpose of captive consumption of the company's plant operations.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content